This is a 9-year, $9,587,256 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the Scripps Research Institute, a renowned nonprofit biomedical research organization in La Jolla, California. The contract is for the Rational Systemic Characterization and Selection of Adjuvants for HIV Vaccine Candidates (R-CASA) project, which involves conducting research and development activities to support the development of HIV vaccine candidates. The contract does not utilize any set-aside designation. As a leading independent research institute, Scripps has a long history of federal research funding, including both prime contract awards and subcontracts, to support projects across a range of biomedical disciplines such as infectious disease, immunology, and drug discovery.
Generated 8/13/24, 11:00 AM